Developer docs
API playgroundTry for free, no card

Search company profiles

BrainScan

Full company profile

uuid0002pqg

Namestring
BrainScan
Legal namestring
BrainScan S.A.
Websiteurl
brainscan.ai
Company typeenum
Public
Founded yearint
2017
Descriptiontext

BrainScan S.A. is a Polish medical AI company founded in 2017 and headquartered in Gdańsk that develops deep learning software for automated detection and triage of brain pathologies in non-contrast CT scans. Its core product, BrainScan CT, uses proprietary convolutional neural networks trained on a database of over 350,000 CT examinations to detect 30 key brain pathologies including hemorrhages, ischemic strokes, and tumors, and generates standardized summary graphics that are embedded directly into DICOM files for seamless integration with hospital PACS workflows. The system is CE MDR 2017/745 certified in the EU and FDA-certified in the US, with a US patent (US 20250272830A1) protecting its DICOM-embedded anomaly detection and summary image generation method. Independent peer-reviewed validation has reported AUC of 0.930 for acute ischemic stroke detection and AUC of 0.983 for hemorrhage detection.

The company serves three primary customer segments: acute care hospitals and emergency departments requiring rapid CT triage, radiology departments and imaging centers seeking AI-assisted interpretation and standardized reporting, and medical education institutions using the BrainScan EDU training platform. The company is publicly listed on the Warsaw Stock Exchange NewConnect market (ticker BSN) following a May 2024 IPO, and is operating across Poland, Germany, Ukraine, Bulgaria, Morocco, and Tunisia. BrainScan generates revenue through multi-year software licensing contracts (typically 36 months) sold via direct enterprise sales and public procurement tenders in Poland, supplemented by distribution partnerships with Synektik (medical imaging), Carebot s.r.o. (Central Europe), and Healthcare Konnect (North Africa), and marketplace revenue share through CARPL.AI's global radiology AI platform.

The business model centers on per-site enterprise licensing of the BrainScan CT system with both cloud and on-premise deployment options, priced through individual public tenders with disclosed contract values typically ranging from €30K to €60K per multi-year engagement. The company has signed strategic partnerships with Aidoc and upmedic to co-develop integrated clinical decision support offerings and has research collaborations with LMU Klinikum München and Provincial Hospital in Poznan for clinical validation. Current strategic priorities include US market entry following FDA certification, expansion of the multimodal diagnostic platform into contrast-enhanced CT analysis and tumor detection (funded by a €2.64M PARP grant running Q1 2025 to Q2 2027), and an active strategic options review initiated in January 2026 to explore mergers, partnerships, or investor transactions aimed at accelerating commercial growth toward profitability.

Short descriptiontext

BrainScan S.A. is a Poland-based medical AI company that develops deep learning software detecting 30+ brain pathologies in non-contrast CT scans, serving hospitals, emergency departments, and radiology centers across Europe with expansion into the US market.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGdansk, Poland
HQ citystring
Gdansk
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiology AI software, brain CT diagnostics, clinical decision support, medical imaging AI, neuroimaging analytics
Industry3 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACAGAA
Diagnostic & Triage Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
Product category
Radiology AI Software
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Software Licensing
TypeSubscription Recurring
Description

AI-powered diagnostic software licensing to hospitals and healthcare institutions. Software is deployed either on-premise or cloud-based, with hospitals purchasing licenses for BrainScan CT system. Revenue generated from license fees, typically structured as multi-year contracts (36-month terms common in public tenders).

brainscan.ai
2Public Tenders and Procurement
TypeOne Time License
Description

Direct sales through public procurement tenders in Poland and internationally. Winning hospital tenders for AI diagnostic systems and educational platforms. Notable contracts include 36-month license agreements with Polish hospitals.

brainscan.ai
3Educational Platform Licensing
TypeSubscription Recurring
Description

Specialized AI-based education platform (Brainscan EDU) for medical education and training in brain CT scan analysis. Deployed in hospital settings for training young physicians and radiologists in training.

brainscan.ai
4Marketplace Revenue Share
TypeTransaction Fee
Description

Revenue sharing arrangement through CARPL.AI marketplace platform. BrainScan receives upper few tens of percent of revenues from each transaction involving BrainScan CT system through the platform.

brainscan.ai
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise Hospital License
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Multi-year contracts, typically 36 months for hospital deployments. Pricing determined through public tender process. Includes system deployment, maintenance, and support.

brainscan.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1BrainScan CT
Description

AI-powered system for automated brain CT analysis and detection of brain pathologies

brainscan.ai
+1 more record
Core offering1 text field

BrainScan develops AI-powered diagnostic software that automatically analyzes non-contrast head CT scans to detect 30 brain pathologies including hemorrhages, ischemic strokes, and tumors. The BrainScan CT system provides instant triage alerts to emergency physicians and generates DICOM-embedded standardized summary images for radiologists, deployed either on-premise or via cloud in hospitals and radiology centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Time to radiologist report reduced by up to 30%
+5 more records
Product overview1 text field

BrainScan offers a unified AI-powered diagnostic platform centered on BrainScan CT, the core product for automated brain CT analysis and clinical decision support. The portfolio includes Brainscan EDU, an educational add-on module for medical training, and an in-development multimodal diagnostic platform expanding into contrast-enhanced CT and tumor detection. The company operates primarily as an on-premise or cloud-deployed software solution, with integrations into third-party platforms like CARPL.AI.

Product and service2 records
1BrainScan CT
CategoryClinical Diagnostic AI Software
Description

AI-powered diagnostic system for automated detection and analysis of brain pathologies in CT scans, providing real-time triage and clinical decision support for radiologists and emergency physicians. Detects 30 brain pathologies including hemorrhages, strokes, and tumors, and generates DICOM-embedded standardized summary images.

2BrainScan EDU
CategoryMedical Education Software
Description

Educational AI platform for brain CT imaging that supports structured learning, case-based education, and decision support for young physicians in training and experienced radiologists. Deployed in hospital and academic settings for radiology residency programs.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-09
Description

Partnership with Healthcare Konnect for BrainScan participation in 25th Franco-Tunisian Radiology Days in Djerba, Tunisia. Collaboration supports growth of modern medical imaging and digital healthcare transformation across North African region.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-03
Description

Strategic distribution agreement covering deployment and commercial expansion of BrainScan CT system in Central Europe. Carebot's strong regional footprint and established customer base create conditions for introducing BrainScan to hospitals and medical networks in new markets. Complementary product portfolios enable comprehensive radiology AI suite offering.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-09-10
Description

Strategic distribution partnership making BrainScan AI solution for CT brain imaging available through Synektik, a leading provider of medical imaging technologies. Partnership strengthens presence in medical imaging market and brings AI-driven diagnostic support to more healthcare institutions.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-11-12
Description

Strategic partnership with global leader in AI-powered medical imaging solutions headquartered in Tel Aviv, Israel. Represents major milestone in mission to revolutionize clinical decision-making through cutting-edge technology and intelligent diagnostics. Collaboration advances AI-driven clinical decision support capabilities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-04-24
Description

Integration partnership making BrainScan CT system available through CARPL.AI's global digital marketplace for radiology AI. Platform aggregates diverse AI models for radiology and enables rapid deployment to healthcare providers. BrainScan receives upper few tens of percent of revenues from each platform transaction. Partnership duration 3 years with termination rights for breach.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

International research collaboration with Ludwig Maximilian University Hospital in Munich for clinical validation and refinement of upcoming features including automated report generation planned for 2026. Supports FDA certification and US market entry strategy.

7Provincial Hospital in Poznan
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Scientific research collaboration with Provincial Hospital in Poznan supporting clinical validation and product development. Partnership generates real-world evidence and testimonial for system effectiveness in emergency settings.

brainscan.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership between BrainScan and upmedic delivering complete AI-powered solution for brain CT diagnostics. Collaboration creates fully integrated, end-to-end solution by combining BrainScan's advanced technology with upmedic's capabilities.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Avicenna.AI
TypeDirect peer
Description

AI company focused on radiology workflow and triage, with overlapping neuro and emergency imaging use cases. Directly comparable as a smaller, specialty radiology AI vendor serving hospitals.

TypeDirect peer
Description

Global leader in AI-powered medical imaging headquartered in Tel Aviv. Both companies provide AI-driven radiology decision support, and Aidoc is also a named BrainScan partner, making it the most directly comparable peer in terms of product surface, customer type, and go-to-market.

TypeDirect peer
Description

Specialist in AI-driven stroke triage and neurovascular workflow. Competes head-to-head in the same emergency neuro CT use case BrainScan targets and serves similar hospital emergency and radiology departments.

TypeDirect peer
Description

AI platform for stroke and brain imaging triage and analytics. Highly comparable in clinical workflow focus (acute ischemic and hemorrhagic stroke) and customer base of stroke-ready hospitals and radiology departments.

TypeDirect peer
Description

AI radiology company with FDA-cleared products across head CT, chest, and lung workflows. Direct overlap with BrainScan in brain CT detection (hemorrhage, stroke) and similar enterprise hospital sales motion.

TypeDirect peer
Description

Specialist in AI-based brain MRI and CT quantification, focused on neurology. Direct competitor in brain-specific imaging AI, with overlapping neuroscience and radiology customer segments.

TypeDirect peer
Description

Comprehensive radiology AI platform covering head CT and other modalities, competing for the same enterprise radiology and emergency department customers.

TypeDirect peer
Description

AI radiology operating system and marketplace; also a named BrainScan collaborator (LMU Munich deployment). Direct overlap in distributing third-party radiology AI models to hospitals through a marketplace model.

TypeEmerging player
Description

AI medical imaging company focused on image enhancement and workflow acceleration. Adjacent rather than direct competitor in brain CT triage, but operates in the same hospital AI procurement budgets and conferences.

TypeOthers
Description

Global digital marketplace for radiology AI models. Listed as a distribution and integration partner rather than competitor, but is a key ecosystem enabler and revenue-share counterpart for BrainScan.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BrainScan

Radiology AI Softwarebrainscan.ai

BrainScan S.A. is a Poland-based medical AI company that develops deep learning software detecting 30+ brain pathologies in non-contrast CT scans, serving hospitals, emergency departments, and radiology centers across Europe with expansion into the US market.

What BrainScan does

BrainScan S.A. is a Polish medical AI company founded in 2017 and headquartered in Gdańsk that develops deep learning software for automated detection and triage of brain pathologies in non-contrast CT scans. Its core product, BrainScan CT, uses proprietary convolutional neural networks trained on a database of over 350,000 CT examinations to detect 30 key brain pathologies including hemorrhages, ischemic strokes, and tumors, and generates standardized summary graphics that are embedded directly into DICOM files for seamless integration with hospital PACS workflows. The system is CE MDR 2017/745 certified in the EU and FDA-certified in the US, with a US patent (US 20250272830A1) protecting its DICOM-embedded anomaly detection and summary image generation method. Independent peer-reviewed validation has reported AUC of 0.930 for acute ischemic stroke detection and AUC of 0.983 for hemorrhage detection.

The company serves three primary customer segments: acute care hospitals and emergency departments requiring rapid CT triage, radiology departments and imaging centers seeking AI-assisted interpretation and standardized reporting, and medical education institutions using the BrainScan EDU training platform. The company is publicly listed on the Warsaw Stock Exchange NewConnect market (ticker BSN) following a May 2024 IPO, and is operating across Poland, Germany, Ukraine, Bulgaria, Morocco, and Tunisia. BrainScan generates revenue through multi-year software licensing contracts (typically 36 months) sold via direct enterprise sales and public procurement tenders in Poland, supplemented by distribution partnerships with Synektik (medical imaging), Carebot s.r.o. (Central Europe), and Healthcare Konnect (North Africa), and marketplace revenue share through CARPL.AI's global radiology AI platform.

The business model centers on per-site enterprise licensing of the BrainScan CT system with both cloud and on-premise deployment options, priced through individual public tenders with disclosed contract values typically ranging from €30K to €60K per multi-year engagement. The company has signed strategic partnerships with Aidoc and upmedic to co-develop integrated clinical decision support offerings and has research collaborations with LMU Klinikum München and Provincial Hospital in Poznan for clinical validation. Current strategic priorities include US market entry following FDA certification, expansion of the multimodal diagnostic platform into contrast-enhanced CT analysis and tumor detection (funded by a €2.64M PARP grant running Q1 2025 to Q2 2027), and an active strategic options review initiated in January 2026 to explore mergers, partnerships, or investor transactions aimed at accelerating commercial growth toward profitability.

BrainScan firmographics

Firmographics
Name
BrainScan
Legal name
BrainScan S.A.
Website
https://brainscan.ai
Company type
Public
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
BrainScan S.A. is a Poland-based medical AI company that develops deep learning software detecting 30+ brain pathologies in non-contrast CT scans, serving hospitals, emergency departments, and radiology centers across Europe with expansion into the US market.
Ownership category
akta.pro rank

BrainScan industry classification

Industry
Product category
Radiology AI Software
NAICS
Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACAGAA
Diagnostic & Triage Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

  • Radiology AI software
  • Brain CT diagnostics
  • Clinical decision support
  • Medical imaging AI
  • Neuroimaging analytics

Where BrainScan is headquartered

Location

Headquarters

HQ city
Gdansk
HQ country
Poland
HQ region
Europe

Offices2 records

Markets served

BrainScan business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Licensing: AI-powered diagnostic software licensing to hospitals and healthcare institutions. Software is deployed either on-premise or cloud-based, with hospitals purchasing licenses for BrainScan CT system. Revenue generated from license fees, typically structured as multi-year contracts (36-month terms common in public tenders).
  2. Public Tenders and Procurement: Direct sales through public procurement tenders in Poland and internationally. Winning hospital tenders for AI diagnostic systems and educational platforms. Notable contracts include 36-month license agreements with Polish hospitals.
  3. Educational Platform Licensing: Specialized AI-based education platform (Brainscan EDU) for medical education and training in brain CT scan analysis. Deployed in hospital settings for training young physicians and radiologists in training.
  4. Marketplace Revenue Share: Revenue sharing arrangement through CARPL.AI marketplace platform. BrainScan receives upper few tens of percent of revenues from each transaction involving BrainScan CT system through the platform.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise Hospital License

Go-to-market motion4 records

Distribution channels5 records

Marketing channels5 records

BrainScan product offering

Product offering

Core offering

BrainScan develops AI-powered diagnostic software that automatically analyzes non-contrast head CT scans to detect 30 brain pathologies including hemorrhages, ischemic strokes, and tumors. The BrainScan CT system provides instant triage alerts to emergency physicians and generates DICOM-embedded standardized summary images for radiologists, deployed either on-premise or via cloud in hospitals and radiology centers.

Product overview

BrainScan offers a unified AI-powered diagnostic platform centered on BrainScan CT, the core product for automated brain CT analysis and clinical decision support. The portfolio includes Brainscan EDU, an educational add-on module for medical training, and an in-development multimodal diagnostic platform expanding into contrast-enhanced CT and tumor detection. The company operates primarily as an on-premise or cloud-deployed software solution, with integrations into third-party platforms like CARPL.AI.

Differentiator

Problem solved

Functional benefit

Brands

  • BrainScan CT: AI-powered system for automated brain CT analysis and detection of brain pathologies
  • BrainScan EDU

Products and services

  • BrainScan CT AI-powered diagnostic system for automated detection and analysis of brain pathologies in CT scans, providing real-time triage and clinical decision support for radiologists and emergency physicians. Detects 30 brain pathologies including hemorrhages, strokes, and tumors, and generates DICOM-embedded standardized summary images.
  • BrainScan EDU Educational AI platform for brain CT imaging that supports structured learning, case-based education, and decision support for young physicians in training and experienced radiologists. Deployed in hospital and academic settings for radiology residency programs.

Quantifiable outcome

  • Time to radiologist report reduced by up to 30%
  • +5 more outcomes

Companies that use BrainScan

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

BrainScan technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature5 records

BrainScan partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • Healthcare KonnectminorChannel Partner/ Reseller/ Distributor · 9 May 2026Partnership with Healthcare Konnect for BrainScan participation in 25th Franco-Tunisian Radiology Days in Djerba, Tunisia. Collaboration supports growth of modern medical imaging and digital healthcare transformation across North African region.
  • Carebot s.r.o.coreChannel Partner/ Reseller/ Distributor · 3 December 2025Strategic distribution agreement covering deployment and commercial expansion of BrainScan CT system in Central Europe. Carebot's strong regional footprint and established customer base create conditions for introducing BrainScan to hospitals and medical networks in new markets. Complementary product portfolios enable comprehensive radiology AI suite offering.
  • SynektikcoreChannel Partner/ Reseller/ Distributor · 10 September 2025Strategic distribution partnership making BrainScan AI solution for CT brain imaging available through Synektik, a leading provider of medical imaging technologies. Partnership strengthens presence in medical imaging market and brings AI-driven diagnostic support to more healthcare institutions.
  • AidoccoreStrategic or Co-development Partner · 12 November 2024Strategic partnership with global leader in AI-powered medical imaging solutions headquartered in Tel Aviv, Israel. Represents major milestone in mission to revolutionize clinical decision-making through cutting-edge technology and intelligent diagnostics. Collaboration advances AI-driven clinical decision support capabilities.
  • CARPL.AIcoreTechnology or Integration · 24 April 2024Integration partnership making BrainScan CT system available through CARPL.AI's global digital marketplace for radiology AI. Platform aggregates diverse AI models for radiology and enables rapid deployment to healthcare providers. BrainScan receives upper few tens of percent of revenues from each platform transaction. Partnership duration 3 years with termination rights for breach.
  • LMU Klinikum MünchencoreStrategic or Co-development PartnerInternational research collaboration with Ludwig Maximilian University Hospital in Munich for clinical validation and refinement of upcoming features including automated report generation planned for 2026. Supports FDA certification and US market entry strategy.
  • Provincial Hospital in PoznancoreStrategic or Co-development PartnerScientific research collaboration with Provincial Hospital in Poznan supporting clinical validation and product development. Partnership generates real-world evidence and testimonial for system effectiveness in emergency settings.
  • upmediccoreStrategic or Co-development PartnerStrategic partnership between BrainScan and upmedic delivering complete AI-powered solution for brain CT diagnostics. Collaboration creates fully integrated, end-to-end solution by combining BrainScan's advanced technology with upmedic's capabilities.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

BrainScan competitors and assessment

Company assessment

Direct peers

  • Avicenna.AI: AI company focused on radiology workflow and triage, with overlapping neuro and emergency imaging use cases. Directly comparable as a smaller, specialty radiology AI vendor serving hospitals.
  • Aidoc: Global leader in AI-powered medical imaging headquartered in Tel Aviv. Both companies provide AI-driven radiology decision support, and Aidoc is also a named BrainScan partner, making it the most directly comparable peer in terms of product surface, customer type, and go-to-market.
  • Viz.ai: Specialist in AI-driven stroke triage and neurovascular workflow. Competes head-to-head in the same emergency neuro CT use case BrainScan targets and serves similar hospital emergency and radiology departments.
  • RapidAI: AI platform for stroke and brain imaging triage and analytics. Highly comparable in clinical workflow focus (acute ischemic and hemorrhagic stroke) and customer base of stroke-ready hospitals and radiology departments.
  • Qure.ai: AI radiology company with FDA-cleared products across head CT, chest, and lung workflows. Direct overlap with BrainScan in brain CT detection (hemorrhage, stroke) and similar enterprise hospital sales motion.
  • icometrix: Specialist in AI-based brain MRI and CT quantification, focused on neurology. Direct competitor in brain-specific imaging AI, with overlapping neuroscience and radiology customer segments.
  • Annalise.ai: Comprehensive radiology AI platform covering head CT and other modalities, competing for the same enterprise radiology and emergency department customers.
  • deepc: AI radiology operating system and marketplace; also a named BrainScan collaborator (LMU Munich deployment). Direct overlap in distributing third-party radiology AI models to hospitals through a marketplace model.

Emerging players

  • Subtle Medical: AI medical imaging company focused on image enhancement and workflow acceleration. Adjacent rather than direct competitor in brain CT triage, but operates in the same hospital AI procurement budgets and conferences.

Others

  • CARPL.AI: Global digital marketplace for radiology AI models. Listed as a distribution and integration partner rather than competitor, but is a key ecosystem enabler and revenue-share counterpart for BrainScan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BrainScan social profiles

Digital presence

BrainScan compliance and trust

Trust signal

Compliance2 records

BrainScan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BrainScan leadership team

Management profile

Number of profiles

Profiles8 records

BrainScan funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BrainScan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BrainScan

What does BrainScan do?

BrainScan develops AI-powered diagnostic software that automatically analyzes non-contrast head CT scans to detect 30 brain pathologies including hemorrhages, ischemic strokes, and tumors. The BrainScan CT system provides instant triage alerts to emergency physicians and generates DICOM-embedded standardized summary images for radiologists, deployed either on-premise or via cloud in hospitals and radiology centers.

Is BrainScan a public or private company?

BrainScan is a public company. It is classified as public and is currently operating.

When was BrainScan founded?

BrainScan was founded in 2017. It employs 11 to 50 people.

Where is BrainScan based?

BrainScan is headquartered in Gdansk, Poland, in the Europe region.

How does BrainScan make money?

Four revenue lines are on record. Software Licensing is the primary driver. The others are public Tenders and Procurement, educational Platform Licensing and marketplace Revenue Share.

Who are BrainScan's main competitors?

Direct peers on record are Avicenna.AI, Aidoc, Viz.ai, RapidAI, Qure.ai, icometrix, Annalise.ai and deepc. Subtle Medical is listed as an emerging player. CARPL.AI is listed as an others.

Does BrainScan have an API?

No public API is recorded for BrainScan.

What industry is BrainScan in?

BrainScan's product category is Radiology AI Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 62151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals